Work

DOP53 Clinical, endoscopic, histological and biomarker activity following treatment with the gut-selective, pan-JAK inhibitor TD-1473 in moderately to severely active ulcerative colitis

Year: 2019

Type: conference-abstract

Source: Journal of Crohn s and Colitis

DOI: 10.1093/ecco-jcc/jjy222.087

Authors: W Sandborn, D Nguyen, B Ferslew, L-Y Hao, T Kanno, L Tomsho, D Boyle, R Graham, B Abhyankar, J Panes

Institutions: University of California San Diego, Theravance Biopharma (United States), Hospital Clínic de Barcelona

Language: English

Topic: Inflammatory Bowel Disease

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2912280048

Cites:

Cited by: 6

Related to: 10